Source abstract
Abstract
Early diagnosis significantly improves survival rates for hepatocellular carcinoma (HCC), yet traditional methods face limitations, including specialized instruments/personnel and prolonged reporting cycles. While lateral flow immunoassay (LFA) offers a promising alternative, its sensitivity and accuracy remain challenged. Here, we present HepatoAI LFA, a machine-learning-assisted nano-enhanced point-of-care system that enables sensitive biomarker detection and digitalized, personalized HCC risk assessment. Taking enzyme-engineered metal-polydopamine frameworks as nanoprobes, a visually amplified LFA is developed for picogram-level detection of α-fetoprotein (AFP) and des-γ carboxyprothrombin (DCP). To assist LFA diagnosis, a machine-learning-based diagnostic model termed F4-ASAD is constructed by incorporating AFP, DCP, and two key predictors, age and sex. End-users input age, sex, and biomarker concentrations into a self-developed F4-ASAD-based online calculator via a smartphone to instantly obtain the HCC risk probability. This integrated system achieves 91.1% accuracy, 93.3% sensitivity, and 86.7% specificity, showing significant potential to streamline clinical workflows and advance precise disease diagnosis.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Biosensors and Analytical Detection · Advanced biosensing and bioanalysis techniques · Hepatocellular Carcinoma Treatment and Prognosis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
State Key Laboratory of Natural Medicines, School of Pharmacy
China Pharmaceutical University
Zhanjiang Institute of Clinical Medicine
Guangdong Medical University Zhanjiang Central Hospital
MOE Joint International Research Laboratory of Animal Health and Food Safety, Key Laboratory of Animal Bacteriology, Ministry of Agriculture, College of Veterinary Medicine
Nanjing Agricultural University
Funding
National Key Research and Development Program of China · Fundamental Research Funds for the Central Universities · National Natural Science Foundation of China · Project Program of State Key Laboratory of Natural Medicines (China Pharmaceutical University) · Postgraduate Research & Practice Innovation Program of Jiangsu Province
References (34)
Show source-provided references